bisoprolol has been researched along with Prostatic Hyperplasia in 2 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present a case where carvedilol was replaced with bisoprolol resulting in acute urinary retention." | 7.77 | Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure? ( Lindenfeld, J; Page, RL; Rohrer, CK; Shakar, SF, 2011) |
| "A case of a 60-year-old male patient, suffering from benign prostatic hyperplasia (BPH), with deterioration of lower urinary tract symptoms (LUTS) during antihypertensive treatment with bisoprolol was presented." | 7.73 | Repeated intensification of lower urinary tract symptoms in the patient with benign prostatic hyperplasia during bisoprolol treatment. ( Chodorowski, Z; Hajduk, A; Sein Anand, J, 2005) |
| " We present a case where carvedilol was replaced with bisoprolol resulting in acute urinary retention." | 3.77 | Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure? ( Lindenfeld, J; Page, RL; Rohrer, CK; Shakar, SF, 2011) |
| "A case of a 60-year-old male patient, suffering from benign prostatic hyperplasia (BPH), with deterioration of lower urinary tract symptoms (LUTS) during antihypertensive treatment with bisoprolol was presented." | 3.73 | Repeated intensification of lower urinary tract symptoms in the patient with benign prostatic hyperplasia during bisoprolol treatment. ( Chodorowski, Z; Hajduk, A; Sein Anand, J, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rohrer, CK | 1 |
| Page, RL | 1 |
| Shakar, SF | 1 |
| Lindenfeld, J | 1 |
| Sein Anand, J | 1 |
| Chodorowski, Z | 1 |
| Hajduk, A | 1 |
2 other studies available for bisoprolol and Prostatic Hyperplasia
| Article | Year |
|---|---|
Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure?
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Male; | 2011 |
Repeated intensification of lower urinary tract symptoms in the patient with benign prostatic hyperplasia during bisoprolol treatment.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Humans; Hypertension; Male; Middle | 2005 |